INS and diabetes mellitus: Conversely, another study [38], investigating the metabolic effects of first-line SRLs or surgery in a large series of acromegalic patients, has demonstrated SRLs to reduce FG, HbA1c, and DM prevalence with disease control, suggesting that improvement in glucose and insulin profile is mainly ascribable to obtaining disease control [38].